| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2013 | CN103271877A Cefoxitin sodium agent and preparation method thereof |
| 09/04/2013 | CN103271876A Enteric coating aureomycin premix and preparation method thereof |
| 09/04/2013 | CN103271875A Marbofloxacin freeze-dried powder for injection and preparation method and application thereof |
| 09/04/2013 | CN103271874A Paclitaxel-encapsulated PEG-PLGA-PEG (Polyethylene Glycol-Polylactic-Co-Glycolic Acid-Polyethylene Glycol) nanoparticle and preparation method thereof |
| 09/04/2013 | CN103271873A Veterinary tiamulin suspension injection and preparation method thereof |
| 09/04/2013 | CN103271872A Industrial production method of penehyclidine hydrochloride injection |
| 09/04/2013 | CN103271870A Carrier delivery system with pluronic trigger release delivery function |
| 09/04/2013 | CN103271832A Synephrine loaded multiple emulsion and preparation method thereof |
| 09/04/2013 | CN103271340A Nanoscale health-care food capable of removing heavy metal in human body and preparation method thereof |
| 09/04/2013 | CN102940882B Medicine for treating respiratory diseases |
| 09/04/2013 | CN102824630B Pharmaceutical composition for treating chicken proventriculitis and preparation method of pharmaceutical composition |
| 09/04/2013 | CN102824352B Application of disaccharide compound in preparing anti-tumor medicine |
| 09/04/2013 | CN102824351B Application of disaccharide compound in preparation of antiviral drug |
| 09/04/2013 | CN102793659B Aspirin suppository and preparation method thereof |
| 09/04/2013 | CN102698043B Medicinal combination for treating thyroid gland |
| 09/04/2013 | CN102697788B Compound lactic acid levofloxacin oral liquid and preparation process thereof |
| 09/04/2013 | CN102697761B 一种布洛芬缓释固体组合物及其制备方法 An extended release solid composition and preparation method ibuprofen |
| 09/04/2013 | CN102670614B Application of compound 6-benzylaminopurine (BA) in preparation of composition for inhibiting oxidative damage of hepatic tissues |
| 09/04/2013 | CN102670501B Orally taken vitamin K1 lipid emulsion |
| 09/04/2013 | CN102670492B Production process for gatifloxacin auristilla |
| 09/04/2013 | CN102633899B Selenized microbial exopolysaccharide, and preparation method and uses thereof |
| 09/04/2013 | CN102631562B Blood-activating, pain-relieving and bone-strengthening ointment |
| 09/04/2013 | CN102600414B Chinese medicinal composition for treating cervical spondylosis |
| 09/04/2013 | CN102600120B Application of cinnamic acid in preparation of drugs for preventing and treating livestock and poultry virus infection |
| 09/04/2013 | CN102580051B Oral liquid for treating hepatitis A |
| 09/04/2013 | CN102579473B Nifuratel-nysfungin gel and preparation method thereof |
| 09/04/2013 | CN102579468B Application of 4-1H-1,2,3-triazole-beta-lactam derivative |
| 09/04/2013 | CN102552930B Water-soluble paclitaxel derivative with cell targeting effect and preparation thereof |
| 09/04/2013 | CN102552221B Tulobuterol patch and preparation method thereof |
| 09/04/2013 | CN102526047B Preparing method of model of monkey with chronic systemic Parkinson's disease |
| 09/04/2013 | CN102512382B Esomeprazole sodium pharmaceutical composition for injection |
| 09/04/2013 | CN102503910B Salicylic acid methyl ester derivative and preparation method and application thereof |
| 09/04/2013 | CN102503908B Vitamin A acid derivative, preparation method thereof, medicine composition thereof and application thereof to preparation anti-tumor medicine |
| 09/04/2013 | CN102503906B Formyl hydroxylamine type peptide deformylase inhibitor containing oxazole ring, as well as preparation method and use thereof |
| 09/04/2013 | CN102499961B Traditional Chinese medicinal composition drug for external use for treating ecthyma and preparation method thereof |
| 09/04/2013 | CN102470130B Crystalline freebase forms of a biphenyl compound |
| 09/04/2013 | CN102451180B External medicine for treating skin diseases and preparation method thereof |
| 09/04/2013 | CN102406631B Method for improving transfer rate of chrysophanol |
| 09/04/2013 | CN102399229B N-acylpyrazole derritol, preparation method thereof, and application thereof |
| 09/04/2013 | CN102389416B Application of farrerol, derivative thereof and pharmaceutically-acceptable salts of farrerol and derivative in preparing medicine for treating heart cerebrovascular disease caused by vasoconstriction |
| 09/04/2013 | CN102381951B Cyclohexanone-contained mono-carbonyl analogues of curcumin and usage thereof |
| 09/04/2013 | CN102370615B 一种布洛芬注射制剂及其制备方法 One kind of injectable formulation of ibuprofen and its preparation method |
| 09/04/2013 | CN102358735B Low toxicity multiple-point guided drug, nitrogen-containing aromatic ring CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
| 09/04/2013 | CN102357132B Yellow tincture itching-relieving liquid medicine |
| 09/04/2013 | CN102319209B Nasal pharmaceutical formulations and methods of using the same |
| 09/04/2013 | CN102295562B Antineoplastic compound, its preparation method and applications |
| 09/04/2013 | CN102281879B Adhesive material containing 5-methyl-1-phenyl-2-(1h)-pyridone |
| 09/04/2013 | CN102274475B Ostalgia moxibustion |
| 09/04/2013 | CN102225913B Rheinic acid derivatives and treatment application thereof |
| 09/04/2013 | CN102219687B Elephantopus scaber extract as well as preparation method and applications thereof in preparing antiviral drugs |
| 09/04/2013 | CN102188386B Nimesulide sustained-release pellets and preparation method thereof |
| 09/04/2013 | CN102159184B Liquid pharmaceutical formulation containing paracetamol |
| 09/04/2013 | CN102147360B Detection method for drug combination |
| 09/04/2013 | CN102089290B Triazole derivatives useful for the treatment of diseases |
| 09/04/2013 | CN102079699B New crystal form for sodium valproate and preparation method and usage thereof |
| 09/04/2013 | CN102066571B Wickerol and process for production thereof |
| 09/04/2013 | CN102066342B Quinoxalinedione derivatives |
| 09/04/2013 | CN102046627B GABAA receptor modulators |
| 09/04/2013 | CN102028742B Drug for treating coronary heart disease and extraction method thereof |
| 09/04/2013 | CN102028741B Medicament for treating coronary heart disease and extraction thereof |
| 09/04/2013 | CN102007122B Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors |
| 09/04/2013 | CN101981037B Pyrazolopyrimidine PI3K inhibitor compounds and methods of use |
| 09/04/2013 | CN101981036B Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors |
| 09/04/2013 | CN101933521B Preparation and application thereof of sterilization composition |
| 09/04/2013 | CN101926998B Expression of embryo type globin induced by adrenoreceptor agonist and application thereof |
| 09/04/2013 | CN101918405B 13a-(s) desoxytylophorinine derivatives, preparation method, pharmaceutical compositon and use thereof |
| 09/04/2013 | CN101918035B Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent |
| 09/04/2013 | CN101854927B Use of anti-bacterial compounds having an anaesthetic effect |
| 09/04/2013 | CN101837003B Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/04/2013 | CN101801386B Anti-angiogenic agents and methods of use |
| 09/04/2013 | CN101796055B Inhibitors of VEGF receptor and HGF receptor signaling |
| 09/04/2013 | CN101743316B Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 09/04/2013 | CN101721708B ED-71 preparation |
| 09/04/2013 | CN101679339B Method for manufacturing neuraminic acid derivatives |
| 09/04/2013 | CN101646669B Purinyl derivatives and their use as potassium channel modulators |
| 09/04/2013 | CN101646442B Therapeutic or prophylactic agent for vasoconstriction |
| 09/04/2013 | CN101633657B Preparation method of palonosetron and palonosetron hydrochloride and injection |
| 09/04/2013 | CN101544596B Preferred crystal-form substance of nitrendipine and preparation method, pharmaceutical composition and application thereof |
| 09/04/2013 | CN101486664B Polysubstituted five membered ring small molecular compound used as influenza virus neuraminidase inhibitor |
| 09/04/2013 | CN101431893B Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| 09/04/2013 | CN101312953B Pharmacologically active compounds containing sulfur |
| 09/04/2013 | CN101269214B EG-VEGF nucleotide and using method |
| 09/04/2013 | CN101265274B Pyrimidinthiazolamine derivatives, and preparation method, medicament composition and use thereof |
| 09/04/2013 | CN101146517B Methods and systems for operating an aerosol generator |
| 09/03/2013 | US8524948 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 09/03/2013 | US8524918 Atropisomer of pyrrole derivative |
| 09/03/2013 | US8524917 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
| 09/03/2013 | US8524910 Pyridyl derivatives as CFTR modulators |
| 09/03/2013 | US8524909 Tetrahydro-pyran derivatives |
| 09/03/2013 | US8524906 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase |
| 09/03/2013 | US8524900 Fused heterocyclic derivatives and methods of use |
| 09/03/2013 | US8524896 Chemical compounds |
| 09/03/2013 | US8524885 Hydrazido derivatives of hyaluronic acid |
| 09/03/2013 | US8524829 Methods for micronization of hydrophobic drugs |
| 09/03/2013 | US8524782 Key intermediate for the preparation of Stilbenes, solid forms of Pterostilbene, and methods for making the same |
| 09/03/2013 | US8524781 Organosulfur compounds, a method of making organosulfur compounds and their use for inhibiting the growth of tumour cells |
| 09/03/2013 | US8524780 Deuterium-enriched bupropion |
| 09/03/2013 | US8524778 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 09/03/2013 | US8524777 Enhanced bimatoprost ophthalmic solution |
| 09/03/2013 | US8524776 Use of polyunsaturated ketones for the treatment of psoriasis |